Company intelligence / Profile preview

Blockpharma

France

Ownership: Private
Development stage: Other

Overview

Blockpharma provides a blockchain-based platform that enables end-to-end traceability of pharmaceutical products, aiming to reduce the prevalence of counterfeit medicines by allowing verification of authenticity at every supply chain step. The system empowers patients and stakeholders to confirm whether their medicines are genuine, using a dedicated mobile app to scan and validate shipment touchpoints[1][2][3][4].

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Blockpharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blockpharma.

Explore the full profile